We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $249.64, moving -1.05% from the previous trading session. This change lagged the S&P 500's 0.17% loss on the day. At the same time, the Dow added 0.03%, and the tech-heavy Nasdaq lost 0.32%.
Heading into today, shares of the largest U.S. health insurer had gained 2.34% over the past month, lagging the Medical sector's gain of 4.86% and the S&P 500's gain of 3.07% in that time.
UNH will be looking to display strength as it nears its next earnings release, which is expected to be July 18, 2019. On that day, UNH is projected to report earnings of $3.47 per share, which would represent year-over-year growth of 10.51%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $60.61 billion, up 8.07% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $14.71 per share and revenue of $243.86 billion. These results would represent year-over-year changes of +14.21% and +7.79%, respectively.
Any recent changes to analyst estimates for UNH should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. UNH currently has a Zacks Rank of #3 (Hold).
Looking at its valuation, UNH is holding a Forward P/E ratio of 17.16. This represents a premium compared to its industry's average Forward P/E of 15.35.
It is also worth noting that UNH currently has a PEG ratio of 1.35. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs industry currently had an average PEG ratio of 1.04 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 20, putting it in the top 8% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $249.64, moving -1.05% from the previous trading session. This change lagged the S&P 500's 0.17% loss on the day. At the same time, the Dow added 0.03%, and the tech-heavy Nasdaq lost 0.32%.
Heading into today, shares of the largest U.S. health insurer had gained 2.34% over the past month, lagging the Medical sector's gain of 4.86% and the S&P 500's gain of 3.07% in that time.
UNH will be looking to display strength as it nears its next earnings release, which is expected to be July 18, 2019. On that day, UNH is projected to report earnings of $3.47 per share, which would represent year-over-year growth of 10.51%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $60.61 billion, up 8.07% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $14.71 per share and revenue of $243.86 billion. These results would represent year-over-year changes of +14.21% and +7.79%, respectively.
Any recent changes to analyst estimates for UNH should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. UNH currently has a Zacks Rank of #3 (Hold).
Looking at its valuation, UNH is holding a Forward P/E ratio of 17.16. This represents a premium compared to its industry's average Forward P/E of 15.35.
It is also worth noting that UNH currently has a PEG ratio of 1.35. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs industry currently had an average PEG ratio of 1.04 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 20, putting it in the top 8% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.